MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer
Cellular Oncology · 2023-10 · 46 (5) · 1213-1234
DOI: 10.1007/s13402-023-00805-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 11.05.2023. Verfasst von Sung-Hsin Kuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Oncology, National Taiwan University Hospital , Taipei, Taiwan. Hauptthemen laut MEDLINE: Breast Neoplasms, MAP Kinase Kinase Kinase 1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and Technology, Taiwan, Ministry of Health and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Oncology, National Taiwan University Hospital , Taipei, Taiwan.
- Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Cancer Research Center, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Departments of Pathology, National Taiwan University Hospital, and College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Surgery, National Taiwan University Hospital, and College of Medicine, National Taiwan University, No. 7, Chung-Shan South Rd, Taipei, Taiwan.
- Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan.
ORCID-Profile: Sung-Hsin Kuo
Förderung
- Ministry of Science and Technology, Taiwan
- Ministry of Health and Welfare
Zitieren
APA
Kuo, S. H., Wei, M. F., Lee, Y. H., Lin, J. C., Yang, W. C., Yang, S. Y., & Huang, C. S. (2023). MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology, 46(5), 1213-1234. https://doi.org/10.1007/s13402-023-00805-w
Vancouver
Kuo SH, Wei MF, Lee YH, Lin JC, Yang WC, Yang SY, et al. MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology. 2023;46(5):1213-1234. doi:10.1007/s13402-023-00805-w
BibTeX
@article{Kuo2023,
author = {Kuo, Sung-Hsin and Wei, Ming-Feng and Lee, Yi-Hsuan and Lin, Jui-Chueh and Yang, Wen-Chi and Yang, Shi-Yi and Huang, Chiun-Sheng},
title = {MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer},
journal = {Cellular Oncology},
year = {2023},
volume = {46},
number = {5},
pages = {1213--1234},
doi = {10.1007/s13402-023-00805-w}
}
EUVIMED